Hi-Clearance - Asset Resilience Ratio

Latest as of September 2025: 2.55%

Hi-Clearance (1788) has an Asset Resilience Ratio of 2.55% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

NT$127.12 Million

≈ $4.00 Million USD Cash + Short-term Investments

Total Assets

NT$4.99 Billion

≈ $157.20 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2016–2024)

This chart shows how Hi-Clearance's Asset Resilience Ratio has changed over time. Check strategic asset allocation of Hi-Clearance to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Hi-Clearance's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 1788 market cap overview.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	NT$0.00	0%
Short-term Investments	NT$127.12 Million	2.55%
Total Liquid Assets	NT$127.12 Million	2.55%

Asset Resilience Insights

Limited Liquidity: Hi-Clearance maintains only 2.55% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Hi-Clearance Industry Peers by Asset Resilience Ratio

Compare Hi-Clearance's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Bio-Rad Laboratories Inc NYSE:BIO	Medical Devices	10.80%
Double Medical Technology Inc SHE:002901	Medical Devices	12.59%
Tellgen Corp SHE:300642	Medical Devices	9.96%
Affluent Medical SAS PA:AFME	Medical Devices	0.03%
Cochlear Ltd AU:COH	Medical Devices	9.76%
Anteris Technologies Global Corp AU:AVR	Medical Devices	33.27%
Imricor Medical Systems Inc AU:IMR	Medical Devices	46.50%
Polynovo Ltd AU:PNV	Medical Devices	0.04%

Annual Asset Resilience Ratio for Hi-Clearance (2016–2024)

The table below shows the annual Asset Resilience Ratio data for Hi-Clearance.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	2.63%	NT$130.66 Million ≈ $4.12 Million	NT$4.96 Billion ≈ $156.28 Million	+0.23pp
2023-12-31	2.40%	NT$110.86 Million ≈ $3.49 Million	NT$4.62 Billion ≈ $145.49 Million	+0.34pp
2022-12-31	2.06%	NT$93.01 Million ≈ $2.93 Million	NT$4.51 Billion ≈ $142.05 Million	+0.72pp
2021-12-31	1.34%	NT$59.55 Million ≈ $1.88 Million	NT$4.44 Billion ≈ $139.80 Million	-0.12pp
2020-12-31	1.47%	NT$61.65 Million ≈ $1.94 Million	NT$4.20 Billion ≈ $132.42 Million	-0.55pp
2019-12-31	2.01%	NT$75.07 Million ≈ $2.37 Million	NT$3.73 Billion ≈ $117.42 Million	-2.36pp
2018-12-31	4.38%	NT$129.95 Million ≈ $4.09 Million	NT$2.97 Billion ≈ $93.55 Million	-1.10pp
2017-12-31	5.48%	NT$143.14 Million ≈ $4.51 Million	NT$2.61 Billion ≈ $82.33 Million	-1.20pp
2016-12-31	6.68%	NT$165.10 Million ≈ $5.20 Million	NT$2.47 Billion ≈ $77.85 Million	--

pp = percentage points

About Hi-Clearance

TWO:1788 Taiwan Medical Devices

Market Cap

$182.35 Million

NT$5.79 Billion TWD

Market Cap Rank

#16834 Global

#808 in Taiwan

Share Price

NT$130.00

Change (1 day)

+0.39%

52-Week Range

NT$129.00 - NT$139.50

All Time High

NT$149.30